BOUNDLESS SCIENCE, LLC

Lancaster, PA · Medtech · Private

Bi-liquid aerosolized ventilation (BAV) device that cools and oxygenates donor lungs using perfluorocarbon liquid aerosols to prevent ischemic damage

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · boundless-science.com

Sector: Medtech
Headquarters: Lancaster, PA
Total capital: $4.2M

Federal grants: $4.2M; 5 awards · 2021–2024; Rank in peer group#204 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 10 pending

Capital timeline

Latest events

May 2024Federal grantDefense · Phase II · Boundless Dha SBIR Phase II Medical Research And Development Contract For "ards Oxygenation Device (aod)"$3M
Aug 2023Federal grantHealth and Human S · Phase I · Extra-Corporeal Oxygenator with Minimal Blood Surface Contact$299K
Sep 2022Federal grantHealth and Human S · Phase I · Aerosol Ventilation to Reduce Ventilator Induced Lung Injury$300K
May 2022Federal grantHealth and Human S · Phase I · Aerosol Ventilation for Rapid Cooling of Transplant Donor Lungs$299K
Sep 2021Federal grantHealth and Human S · Phase I · Ultrasound Enhanced Extracorporeal Membrane Oxygenation$300K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#204 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 10

Jan 4, 2024PendingMethod And Apparatus For Enhanced TransportUSPTOApplication 18039938
Nov 30, 2023PendingSystems, Devices And Methods For Delivering Aerosolized FluorocarbonsUSPTOApplication 18031565
PendingExtracorporeal Oxygenation DeviceUSPTOApplication 63403659

Show all 10 patent records

Method And Apparatus For Enhanced TransportJan 4, 2024 · Application 18039938Pending
Systems, Devices And Methods For Delivering Aerosolized FluorocarbonsNov 30, 2023 · Application 18031565Pending
Extracorporeal Oxygenation DeviceApplication 63403659Pending
Method And Apparatus For Enhanced TransportApplication 63347440Pending
Method And Apparatus For Enhanced TransportApplication PCTUS2021061447Pending
Systems, Devices And Methods For Delivering Aerosolized FluorocarbonsApplication PCTUS2021054545Pending
Methods and Apparatus for Enhanced TransportApplication 63120126Pending
Extracorporeal Oxygenation DeviceApplication 63566576Pending
Apparatus and Methods for Improved Function of Lung TissueApplication 63090565Pending
Method And Apparatus For Enhanced TransportApplication PCTUS2023017184Pending

BOSE CORPORATIONSimilar federal contract value in Medtech · null in contracts
AESTAS PHARMA INC.Similar federal contract value in Medtech · null in contracts
PreTel, Inc.Similar federal contract value in Medtech · null in contracts
INDEPENDENT FEEDING DEVICE, LLCSimilar federal contract value in Medtech · null in contracts
ROSE DIAGNOSTICS INC.Similar federal contract value in Medtech · null in contracts
T-NEURO, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.